Address the cost barrier
The earlier IPO Fund site describes its aim as widening access to public markets by financing the work that precedes an IPO.
IPO Cascade is designed to finance approved IPO costs by paying professional suppliers directly. It focuses on the transaction budget, not unrestricted cash for company operations.
The fund is in formation. This site does not make a financing commitment. Terms shown are indicative and may change.
A company may need an IPO to raise capital, yet still need to pay for the professional work that must happen before proceeds are available. IPO Cascade is designed around that sequencing gap.
The Cascade page describes the fund designating companies that are ready to go public but lack the capital for IPO expenses. The process and selection criteria are not fully set out. The proposed fund would pay approved suppliers for specified IPO work rather than make an unrestricted cash transfer to the company, and would supervise execution.
Financing professional costs does not fund payroll, production, sales or other operating needs unless a separate arrangement expressly does so. The company still needs an operating-liquidity plan.
A discussion, application, readiness review or indicative proposal is not approval to spend. Financing remains subject to assessment, available capital, applicable requirements and definitive agreements.
The earlier IPO Fund site describes its aim as widening access to public markets by financing the work that precedes an IPO.
The stated mission is to finance the journey to public markets and participate in the value that journey may create.
The earlier site names integrity, transparency, disciplined stewardship and alignment of interests as its values.
A category is not automatic authorization. Eligibility depends on the project, supplier engagement and definitive financing terms.
Offering-document preparation, transaction agreements, corporate diligence and responses to filing comments, under counsel’s engagement.
External audit, financial-statement preparation support, accounting advice and transaction reporting, with scopes that respect management and auditor responsibilities.
Filing agents, document production, permitted filing fees, translation and listing-application expenses where relevant to the proposed offering.
Some external governance, internal-control, transfer-agent, registry or insurance-related work may be considered when directly tied to the agreed project.
Presentation production, investor-communication support and permitted roadshow logistics, coordinated with securities counsel and responsible professionals.
Identify supplier, service, amount, timing, deliverable, assumptions and reason the expense is necessary to the transaction.
Historical invoices, related-party charges, cancellation fees, underwriting compensation, deposits, taxes, travel and overruns need express treatment. Do not assume they qualify.
The financing path is intended to move from information to evaluation, agreement and then authorized disbursement.
Share a concise business description, ownership overview, available financial information, IPO rationale, advisers and estimated funding gap.
Consider business credibility, reporting, governance, management capacity, professional team and a realistic route to completion.
List suppliers, scopes, deliverables, payment dates, assumptions, existing commitments, contingencies and change-control rules.
Set the financing ceiling, payment conditions, fees or other compensation, repayment, reporting, risk allocation and non-completion terms.
Verify the approved invoice, work status, available budget and independently confirmed payment instructions.
Review spending and changes. At closing or another outcome, reconcile amounts under the signed agreement.
The source sites establish no universal minimum revenue, profitability, valuation, financing amount or IPO size. Readiness depends on the issuer, market and offering route.
Explain the company’s business and revenue model, why public ownership fits, and how the offering serves a defined commercial objective. Address customer concentration, material contracts and assumptions.
Identify available financial periods, audit status and accounting issues. Explain how ordinary operations will be funded while the IPO is prepared and if the timetable extends.
Prepare an accurate capitalization and ownership summary, governing documents, material debt, board arrangements, disputes, contingent liabilities and related-party dealings.
List engaged advisers, open roles and discussions with prospective underwriters. An adviser’s appointment is not a commitment to underwrite, approve or complete an IPO.
Identify internal owners for key workstreams, the records management can provide and the time needed to support diligence and decisions alongside normal operations.
Show the full economics, alternatives, downside exposure, net proceeds and decision rights. Agree what changes would require reassessment or a pause.
A “not yet” answer identifies a gap to address. A positive financing assessment would not be exchange approval, SEC approval, underwriting commitment or a guarantee of investor demand.
Repayment from IPO proceeds describes an intended source. It does not determine every obligation if the offering is smaller, delayed or unsuccessful.
A budget is a project-control record, not just a total estimate. Include scope, supplier, payment basis, timing, assumptions and a cost-to-complete view.
| Budget view | What it captures | Why it matters |
|---|---|---|
| Paid | Financed amounts already disbursed and any deposits or refunds. | Shows cash already used and possible credits. |
| Committed | Approved but unpaid invoices, contracts and work engaged but not yet invoiced. | Prevents the budget from overstating what remains available. |
| Cost to complete | Latest estimate to reach the next decision point and the contemplated closing. | Tests whether the remaining authorization can finish the critical path. |
| Changes and contingencies | Change requests, taxes, expenses, cancellation terms and any reserve release. | A reserve is not automatic spending authority; changes require documented approval. |
Practical milestones may include a completed diligence package, delivery of financial statements or a draft filing. “The IPO succeeds” is not a useful payment condition for every professional service performed before closing.
Illustrative arithmetic only: on a hypothetical $1,000,000 budget ceiling, if $160,000 is paid and $90,000 is committed but unpaid, $750,000 remains uncommitted. This is not an IPO cost estimate, an offer, actual financing or proof of available cash.
Each participant retains a distinct role. The engagement documents should show who provides information, approves work, authorizes payments and resolves issues.
Management operates the business, provides reliable records and makes company decisions. The board evaluates the financing, alternatives and downside within its responsibilities.
Each professional performs the scope in its own engagement. A payment by the financier does not create a new client relationship, transfer professional authority or remove independence and confidentiality duties.
Underwriting, distribution and exchange admission are separate. Interest in a transaction is not necessarily a binding underwriting commitment or approval.
The financier administers the financing, approved supplier payments, monitoring and settlement rights stated in the documents. It does not thereby become the issuer’s law firm, auditor, underwriter or exchange.
Engagements should identify the client, service scope, fee basis, dates, expenses, deliverables, cancellation terms and authorized invoicing details. Changes to payment instructions need independent authentication.
Identify related parties, introducer compensation, changed scopes and disputed invoices. No referral fee or supplier appointment is created by an introduction alone. New work, overruns or material changes require approval.
Direct supplier payments can make spending more visible. They cannot assure an IPO succeeds or make all project costs recoverable.
Budget, timetable and advisers can change. The issuer may remain responsible for funded amounts, supplier work, termination costs or other obligations, depending on the signed terms.
A smaller or delayed IPO can reduce net capital available. Repayment, supplier bills and financing charges should be reconciled against actual proceeds and the company’s operating needs.
Legal, audit and other services are consumed as performed. If the IPO stops, those services may have little sale value. Stopping future payments does not erase existing liabilities.
A financing assessment does not guarantee SEC clearance, exchange admission, listing, investor demand, valuation or closing. SEC filing review is not an endorsement of investment merits.
Direct payments, invoice checks and staged disbursements do not eliminate fraud, cyber incidents, error, professional underperformance or misrepresentation.
Agree which changes require a review or pause: financial deterioration, accounting issues, adviser withdrawal, a reduced offer or a weaker route to completion.
Every financing is subject to evaluation, available capital, applicable requirements and definitive agreements.
The Cascade page describes the fund as in formation. This site does not make a financing commitment. Any project would require evaluation and signed documents.
Potentially approved legal, audit, accounting, filing, listing-preparation, governance, transfer-agent setup, transaction communications and related professional costs. Each item needs a defined scope and express budget approval.
No. The proposed model is supplier-paid. It is not a general-purpose working-capital facility and does not replace the company’s operating-liquidity plan.
The new Cascade page lists a 15%–25% participation in the company and reimbursement from IPO proceeds, with twice the IPO cost described as a proposal. The older site describes different economics. The form and amount are not settled here.
The new Cascade page says costs rest with the issuer and that documents will define the terms. Earlier pages say the agreement controls and warn that obligations may remain. Resolve maturity, recourse, security, extension and termination terms before funding begins.
The new Cascade page describes successive companies taking on the same commitment. The earlier IPO Fund pages say no successor obligation arises just from the website or the concept. Any such obligation needs to be explicit in signed documents.
No. An assessment can identify further work, request more information, defer or decline a project. It is not SEC or exchange approval, underwriting commitment or a guarantee of investor demand.
No. The issuer, its management and board, counsel, auditors, underwriter, suppliers and exchange each have separate roles.
No. Send only a non-confidential introduction first. Sensitive material should be exchanged through an agreed secure process and, where appropriate, a confidentiality agreement.
Condensed from the distinct IPO Fund articles linked on the earlier site.
The offering itself has a financing requirement before it can raise capital. Incubation addresses a defined transaction plan rather than an undeveloped business idea.
It describes budget and payment discipline. An unfinished IPO is not necessarily a saleable asset and the analogy creates no collateral, insurance or principal protection.
A profession label is not enough. Each expense needs an identified supplier, scope, timing, engagement and reason it belongs in the approved project.
Supplier-paid financing and equity investment create different uses of capital, rights and obligations. Compare total cost, repayment, control and dilution, including dilution from the IPO itself.
Financial reporting, ownership records, governance, management capacity and operating liquidity should be reviewed before downstream work becomes expensive.
Track paid amounts, unpaid invoices, contractual commitments, contingency releases, changes and cost to complete. A budget ceiling alone does not prove the project is fully funded.
Model gross proceeds, financing settlement, underwriting and other deductions, then check the amount left for the company’s actual plan. Avoid double-counting supplier invoices already paid.
Settle treatment of paid work, unbilled services, deposits, cancellation charges, maturity and alternative financing events before the first invoice is financed.
Management, board, advisers, underwriter, financier, regulator and exchange have different responsibilities. A payment role is not a professional or regulatory approval.
Incubation concerns one transaction. Cascade concerns possible links between transactions. Capital recycling is conditional and does not automatically bind an issuer to finance successors.
Ask why an IPO fits, what the facility pays, whether the critical path is funded, total economics, ownership effects, spending authority, net proceeds, failure consequences, conflicts and stop conditions.
Verify supplier identity and payment instructions independently. Invoice checks improve administration but cannot guarantee the service, offering or recovery.
The source site states that the process is covered by United States Patent US 12,548,076 B2.
Read Marc Deschenaux’s article on the IPO Cascade. The earlier IPO Fund site lists Marc Deschenaux as Founder & CEO.
A useful introduction covers what the company does, why it is considering an IPO, the intended market, reporting status, professional team and estimated unfunded costs. A fixed IPO date is not required.
Do not send identity documents, bank information, privileged communications or sensitive records by email. An enquiry does not establish confidentiality, a supplier appointment, financing approval or a referral fee.
Email listed on the earlier site
info@ipofund.us
This packaged website is static. It does not collect, store or transmit form submissions.
Rue François Bonivard 10, 6th Floor
1201 Geneva, Switzerland
Phone: +41 22 510.25.00
Fax: +41 22 510.25.01
1334 Westwood Boulevard, Suite 6
Los Angeles, CA 90024
United States
Phone: +1 310 871 3668
30 Wall Street, 8th Floor
New York, NY 10005
United States
Phone: +1 (561) 827-1180
These details are carried over from IPOFund.us. Confirm them through current official materials before relying on them.